{"database": "lobbying", "table": "lobbying_activities", "rows": [[2300271, "5f40b351-430d-4e25-b6cc-9b8e67ceefe1", "Q2", "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 1466, "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 2019, "second_quarter", "MMM", "On April 22, 2019 AACC wrote to the Government Accountability Office urging it to conduct a study on the impact of the Protecting Access to Medicare Act on patient access to  laboratory services and low-volume laboratories. The GAO had released a report in November 2018, which addressed implementation issues associated with the law, but had neglected these two areas.", "Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,SENATE", null, 80000, 0, 0, "2019-07-09T13:47:05.090000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2300271"], "units": {}, "query_ms": 0.4202019772492349, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}